Category: Mergers & Acquisitions
Botox-maker Allergan announces restructuring measures that will cut 13% of its global workforce as the company sinks deeper into a months-long battle against activist investors and attempts at a takeover.
Updated July 21, 2014, at 12:40 p.m. EST with additional information on Allergan's earnings.
Activist investor Bill Ackman urges shareholders to take action before time runs out on Valeant Pharmaceuticals' hostile $53 billion bid to acquire Allergan.
Abbott chairman & CEO Miles White chides critics of corporate inversions as Capitol Hill mulls legislation to strip tax benefits for companies that shift their headquarters overseas.
Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.
Medtronic ensures shareholders that the company remains beholden to (nearly) all U.S. corporate taxes as it shifts its headquarters overseas.
Lawmakers aim to prohibit companies from shifting their headquarters overseas in order to evade U.S. taxes, a measure that would apply retroactively to deals such as Medtronic's $43 billion acquisition of Covidien.
Johnson & Johnson CEO Alex Gorsky says the healthcare giant is eyeing acquisitions to bolster its 'subscale' cardiovascular business and, possibly, other aspects of its medical device business.
The world's largest medical device operation is eyeing acquisitions to bolster its "subscale" cardiovascular business, particularly its electrophysiology business, Johnson & Johnson (NYSE:JNJ) chairman & CEO Alex Gorsky told analysts yesterday.